Statin Treatment in Specific Patient Groups: Role for Improved Cardiovascular Risk Markers

Ample evidence supports the use of statin therapy for secondary prevention in patients with a history of atherosclerotic cardiovascular disease (ASCVD), but evidence is wanting in the case of primary prevention, low-risk individuals, and elderly adults 65+. Statins are effective in lowering low-dens...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Alyssa M. B., Mishcon, Hillary R., Redwanski, John L., Hills, Ronald D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700563/
https://www.ncbi.nlm.nih.gov/pubmed/33233352
http://dx.doi.org/10.3390/jcm9113748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700563/
https://www.ncbi.nlm.nih.gov/pubmed/33233352
http://dx.doi.org/10.3390/jcm9113748

Ejemplares similares